ProgestogensBiomarker1 paperHumans1LatestNov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 2Sep 2026: 9Oct 2026: 315Annals of Internal MedicineReview·YesterdayPharmacologic Treatments for Females With Menopausal Vasomotor Symptoms: A Clinical Guideline From the American College of PhysiciansIndustry & policyAnnals of Internal MedicineReview·YesterdayPharmacologic Treatments for Female Menopausal Vasomotor Symptoms: A Systematic Review and Meta-analysis for the American College of PhysiciansReproductive systemScienceReview·2 OctReframing menopause and menopause hormone therapy as opportunities for healthy agingInterventionsbioRxivAnimalsPreprint·26 SepEfficacy of postmenopausal estrogen replacement in SIV-infected female macaques on antiretroviral therapyInterventionsPreprints.orgReviewPreprint·24 SepEstrogen, Progesterone, and Testosterone in the Menopausal Transition: Hair Biology, Clinical Consequences, and a Risk-Benefit Framework for Hormonal Assessment and TreatmentInterventionsHeadacheHumans·15 SepHormonal treatments and migraine characteristics across reproductive stages and transition to menopause: A cross-sectional studyPopulationsInvestigative Ophthalmology & Visual ScienceHumans·14 SepPre-Diagnostic Plasma Endogenous Steroids and the Risk of Exfoliation GlaucomaEyeJournal of the National Cancer InstituteHuman trial·10 SepEndocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer PreventionInterventionsJournal of Menopausal MedicineReview·8 SepExpanding the Horizons of Menopausal Hormone Therapy: A Narrative Review of Progestogen-Only and Testosterone-Only Strategies for Tailored ManagementInterventionsJAMA Internal MedicineHumans·8 SepMenopausal Hormone Therapy and Cardiovascular Risk in Midlife Women With Vasomotor SymptomsCardiovascular disease
Annals of Internal MedicineReview·YesterdayPharmacologic Treatments for Females With Menopausal Vasomotor Symptoms: A Clinical Guideline From the American College of PhysiciansIndustry & policy
Annals of Internal MedicineReview·YesterdayPharmacologic Treatments for Female Menopausal Vasomotor Symptoms: A Systematic Review and Meta-analysis for the American College of PhysiciansReproductive system
ScienceReview·2 OctReframing menopause and menopause hormone therapy as opportunities for healthy agingInterventions
bioRxivAnimalsPreprint·26 SepEfficacy of postmenopausal estrogen replacement in SIV-infected female macaques on antiretroviral therapyInterventions
Preprints.orgReviewPreprint·24 SepEstrogen, Progesterone, and Testosterone in the Menopausal Transition: Hair Biology, Clinical Consequences, and a Risk-Benefit Framework for Hormonal Assessment and TreatmentInterventions
HeadacheHumans·15 SepHormonal treatments and migraine characteristics across reproductive stages and transition to menopause: A cross-sectional studyPopulations
Investigative Ophthalmology & Visual ScienceHumans·14 SepPre-Diagnostic Plasma Endogenous Steroids and the Risk of Exfoliation GlaucomaEye
Journal of the National Cancer InstituteHuman trial·10 SepEndocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer PreventionInterventions
Journal of Menopausal MedicineReview·8 SepExpanding the Horizons of Menopausal Hormone Therapy: A Narrative Review of Progestogen-Only and Testosterone-Only Strategies for Tailored ManagementInterventions
JAMA Internal MedicineHumans·8 SepMenopausal Hormone Therapy and Cardiovascular Risk in Midlife Women With Vasomotor SymptomsCardiovascular disease